Form 8-K · Current report
Ameren 8-K, filed Aug 24, 2026
- Filed
- CIK
- 0001002910
- Accession no.
- 0001104659-26-100236
Summary
Ameren Illinois Company, a subsidiary of Ameren Corporation, sold $400 million principal amount of 5.50% First Mortgage Bonds due 2036, receiving net offering proceeds of approximately $397.4 million before expenses. The bonds were offered under a shelf registration statement effective August 4, 2026 and a prospectus supplement dated August 17, 2026.
Key points
- Ameren Illinois sold $400 million principal amount of 5.50% First Mortgage Bonds due 2036 on August 24, 2026.
- Net offering proceeds were approximately $397.4 million before expenses.
- The offering was made under a Form S-3 registration statement effective August 4, 2026, with a prospectus supplement dated August 17, 2026.
- Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., SMBC Nikko Securities America, Inc. and TD Securities (USA) LLC acted as representatives of the underwriters.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
ITEM 8.01 Other Events. On August 24, 2026, Ameren Illinois Company (“Ameren Illinois”), a subsidiary of Ameren Corporation, sold $400 million principal amount of its 5.50% First Mortgage Bonds due 2036 (the “Bonds”). The Bonds were offered pursuant to a Registration Statement on Form S-3 (File No. 333-297949-01), which became effective on August 4, 2026, and a Prospectus Supplement dated August 17, 2026, to a Prospectus dated August 4, 2026. Ameren Illinois received net offering proceeds of approximately $397.4 million, before expenses, upon closing of the transaction. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.